The economic impact of epilepsy-related morbidity and mortality is worse in resource poor countries

Takeaway

  • The economic consequences of epilepsy-related morbidity and mortality are substantial and, after adjustment for gross domestic product (GDP), this financial impact disproportionately affects resource poor countries.

Why this matters

    This is the first global estimate of the macroeconomic burden of epilepsy and the findings extend previous descriptions of the direct and indirect economic burden associated with epilepsy from the societal, health system and household perspective.